Homo sapiens Protein: ABL2 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||
InnateDB Protein | IDBP-246463.6 | ||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||
Gene Symbol | ABL2 | ||||||||||||||||||||||||||||
Protein Name | v-abl Abelson murine leukemia viral oncogene homolog 2 | ||||||||||||||||||||||||||||
Synonyms | ABLL; ARG; | ||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000375897 | ||||||||||||||||||||||||||||
InnateDB Gene | IDBG-105099 (ABL2) | ||||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||
Function | Non-receptor tyrosine-protein kinase that plays an ABL1- overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin- bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 acts also as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. {ECO:0000269PubMed:15735735, ECO:0000269PubMed:15886098, ECO:0000269PubMed:16678104, ECO:0000269PubMed:17306540, ECO:0000269PubMed:18945674}. | ||||||||||||||||||||||||||||
Subcellular Localization | Cytoplasm, cytoskeleton. | ||||||||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||||||||
Tissue Specificity | Widely expressed. | ||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 51 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||
InterPro |
IPR000719
Protein kinase domain IPR000980 SH2 domain IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain IPR001452 SH3 domain IPR002290 Serine/threonine/dual specificity protein kinase, catalytic domain IPR003646 SH3-like domain, bacterial-type IPR011009 Protein kinase-like domain IPR011511 Variant SH3 domain IPR020635 Tyrosine-protein kinase, catalytic domain |
||||||||||||||||||||||||||||
PFAM |
PF00069
PF00017 PF14633 PF07714 PF00018 PF14604 PF08239 PF08460 PF07653 |
||||||||||||||||||||||||||||
PRINTS |
PR00401
PR00109 PR00452 |
||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||
SMART |
SM00252
SM00326 SM00220 SM00287 SM00219 |
||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||
SwissProt | P42684 | ||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P42684 | ||||||||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||
Entrez Gene | 27 | ||||||||||||||||||||||||||||
UniGene | Hs.630545 | ||||||||||||||||||||||||||||
RefSeq | NP_001129473 | ||||||||||||||||||||||||||||
HUGO | HGNC:77 | ||||||||||||||||||||||||||||
OMIM | 164690 | ||||||||||||||||||||||||||||
CCDS | CCDS44283 | ||||||||||||||||||||||||||||
HPRD | 01259 | ||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||
EMBL | AK311045 AL139132 AL359179 AL512326 BC065912 BX538317 CH471067 DQ009672 FJ542283 FJ542284 FJ542285 FJ542286 M35296 | ||||||||||||||||||||||||||||
GenPept | AAA35553 AAH65912 AAY16984 ACK76601 ACK76602 ACK76603 ACK76604 CAD98092 CAH70921 CAH70925 CAI13566 CAI13570 CAI15584 CAI15585 EAW91040 | ||||||||||||||||||||||||||||